Original Research
Accepted on 09 Feb 2026
Cost-Effectiveness of Hetrombopag, Eltrombopag, and Avatrombopag for Chronic Immune Thrombocytopenia in China: A Cost-Utility Analysis
in Health Economics
Original Research
Accepted on 09 Feb 2026
in Health Economics
Original Research
Accepted on 09 Feb 2026
in Neuropharmacology
Original Research
Accepted on 09 Feb 2026
in Atmosphere and Climate
Review
Accepted on 09 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Case Report
Accepted on 09 Feb 2026
in Genitourinary Oncology
Original Research
Accepted on 09 Feb 2026
in Molecular Diagnostics and Therapeutics
Original Research
Accepted on 09 Feb 2026
in Physical Activity in the Prevention and Management of Disease
Case Report
Accepted on 09 Feb 2026
in Head and Neck Cancer
Original Research
Accepted on 09 Feb 2026
in Advanced Clean Fuel Technologies
Original Research
Accepted on 09 Feb 2026
in Primary Immunodeficiencies
Original Research
Accepted on 09 Feb 2026
in Land Use Dynamics
Original Research
Accepted on 09 Feb 2026
in Addictive Disorders
Original Research
Accepted on 09 Feb 2026
in Clinical Nutrition
Original Research
Accepted on 09 Feb 2026
in Genetics of Common and Rare Diseases
Review
Accepted on 09 Feb 2026
in Soil Processes
Original Research
Accepted on 09 Feb 2026
in Infectious Agents and Disease